Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 3
2010 3
2011 2
2012 1
2013 2
2014 1
2015 1
2016 6
2017 2
2018 4
2019 1
2020 3
2021 6
2022 7
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
miR-221 and Parkinson's disease: A biomarker with therapeutic potential.
Zamanian MY, Ivraghi MS, Gupta R, Prasad KDV, Alsaab HO, Hussien BM, Ahmed H, Ramadan MF, Golmohammadi M, Nikbakht N, Oz T, Kujawska M. Zamanian MY, et al. Among authors: kujawska m. Eur J Neurosci. 2024 Jan;59(2):283-297. doi: 10.1111/ejn.16207. Epub 2023 Dec 3. Eur J Neurosci. 2024. PMID: 38043936 Review.
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
Zamanian MY, Parra RMR, Soltani A, Kujawska M, Mustafa YF, Raheem G, Al-Awsi L, Lafta HA, Taheri N, Heidari M, Golmohammadi M, Bazmandegan G. Zamanian MY, et al. Among authors: kujawska m. Mol Biol Rep. 2023 Jun;50(6):5455-5464. doi: 10.1007/s11033-023-08409-1. Epub 2023 May 8. Mol Biol Rep. 2023. PMID: 37155008 Review.
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings.
Zamanian MY, Terefe EM, Taheri N, Kujawska M, Tork YJ, Abdelbasset WK, Shoukat S, Opulencia MJC, Heidari M, Alesaeidi S. Zamanian MY, et al. Among authors: kujawska m. CNS Neurol Disord Drug Targets. 2023;22(10):1453-1461. doi: 10.2174/1871527322666221005122408. CNS Neurol Disord Drug Targets. 2023. PMID: 36200161 Review.
51 results